BIO-Europe 2026
Talk Presenting Companies (Theatre A) track
CNS/Neurology: BIORCHESTRA Co., Ltd.
Tue, Nov 10, 2026 · 2:00–2:15 PM CET Koelnmesse
About this session
BIORCHESTRA is a biotechnology company developing RNA therapeutics for central nervous system (CNS) diseases. Its proprietary BDDS™ platform is designed to enable systemic delivery of oligonucleotide therapeutics across the blood-brain barrier and into brain parenchyma following intravenous administration.
Speaker
-
CEO · BIORCHESTRA Co., Ltd.
Speaker